Updated Jul 16, 2026
Maheshwari Anshul has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $691K.
Anshul Maheshwari is the Chief Financial Officer of SI-BONE, Inc., a medical device company specializing in minimally invasive surgical implant systems. He has been involved in the company's financial operations, contributing to its growth and development in the medical device sector.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.6K | $16.73 | $26K |
| 2026-07-06 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.8K | $16.80 | $30K |
| 2026-05-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.2K | $14.65 | $32K |
| 2026-05-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.5K | $14.71 | $36K |
| 2026-04-03 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.6K | $12.81 | $20K |
| 2026-04-03 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.8K | $12.92 | $23K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.9K | $15.41 | $60K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 3.1K | $15.46 | $47K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.2K | $15.29 | $33K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 11.1K | $15.36 | $171K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.3K | $15.35 | $20K |
| 2026-02-19 | SIBN | SI-BONE, Inc. | A — Grant or award | 13.5K | $0.00 | |
| 2026-02-19 | SIBN | SI-BONE, Inc. | A — Grant or award | 13.5K | $0.00 | |
| 2026-02-19 | SIBN | SI-BONE, Inc. | A — Grant or award | 81.0K | $0.00 | |
| 2025-10-02 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.6K | $14.17 | $22K |
| 2025-10-02 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.8K | $14.22 | $25K |
| 2025-08-18 | SIBN | SI-BONE, Inc. | S — Open-market sale | 2.2K | $15.55 | $34K |
| 2025-08-18 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.3K | $15.59 | $20K |
| 2025-07-02 | SIBN | SI-BONE, Inc. | S — Open-market sale | 867 | $18.43 | $16K |
| 2024-11-20 | SIBN | SI-BONE, Inc. | S — Open-market sale | 1.3K | $12.67 | $16K |
Anshul Maheshwari is the Chief Financial Officer of SI-BONE, Inc., a medical device company specializing in minimally invasive surgical implant systems. He has been involved in the company's financial operations, contributing to its growth and development in the medical device sector.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 20 open-market sales ($691K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Maheshwari Anshul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.